Skip to main content
Clinical Trials/NCT04969783
NCT04969783CompletedNot Applicable

Telehealth Study Assessing the Removal of Filter Ventilation on Smoking Behavior and Biomarkers

Masonic Cancer Center, University of Minnesota4 sites in 1 country164 target enrollmentStarted: May 26, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
164
Locations
4
Primary Endpoint
Change in Cigarettes Per Day (CPD)

Study Overview

Brief Summary

The goals of this project are to determine the effects of varying degrees of cigarette filter ventilation on biomarkers of toxicant exposure and smoking behavior and on subjective responses to the cigarette.

The primary aim of this study is to examine the effects of unventilated vs ventilated filter cigarettes on urinary biomarkers of toxicant exposure and smoking behavior (e.g., cigarettes per day, intensity of smoking). The secondary objectives are 1) to examine the effects of cigarette filter ventilation on subjective measures such as cigarette dependence and responses to study cigarettes.

Detailed Description

This randomized controlled multi-site study will assess the effect of cigarettes with unventilated vs. ventilated filters on smoking behavior and biomarkers of tobacco toxicant exposure. The study, using telehealth and brief visits, will also examine the feasibility of remote collection of multiple biological samples.

Subjects (N=164; N=82 in each group) will be randomly assigned to: 1) Ventilated cigarettes; or 2) Unventilated cigarettes. Smokers will undergo an in person screening and then a 9 week experimental trial; 1 week of usual brand cigarettes; 2 weeks of ventilated study cigarettes and 6 weeks on either the ventilated or unventilated study cigarettes.

Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per day will be collected remotely. Biological samples collected at home will be dropped off at the clinic where the study cigarettes will be dispensed.

Biomarker samples will be assessed for total nicotine equivalents, tobacco specific nitrosamines and volatile organic compound.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Single (Participant)

Masking Description

Single blind

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • At least 21 years of age
  • Biochemically confirmed regular cigarette smoker
  • Daily smoker, 5-30 cigarettes per day.
  • Usual brand cigarettes 16-36% ventilation

Exclusion Criteria

  • Unstable health
  • Unstable medications
  • Pregnant or nursing

Outcomes

Primary Outcomes

Change in Cigarettes Per Day (CPD)

Time Frame: 7 days prior to week 0 visit and 7 days prior to week 6 visit

Change in cigarettes per day, daily diary reviewed data.

Change in Total NNAL: 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol [ng/g Creatinine]

Time Frame: 6 weeks randomized intervention

Absolute change from baseline level of total NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) at the week 6 visit (ng/g creatinine) measured in urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials

Telehealth-Filter Ventilation ( COMET2P1 ) | Clinical Trial